This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Nov;40(11):e645; author reply e646.

doi: 10.1161/STROKEAHA.109.561191. Epub 2009 Sep 24.

Platelet dysfunction in intraparenchymal hemorrhage

Claire J Creutzfeldt, Kyra J Becker, W T Longstreth Jr, David L Tirschwell, Jonathan R Weinstein

PMID: 19797180
PMCID: PMC8930190
DOI: 10.1161/STROKEAHA.109.561191

Comment

Platelet dysfunction in intraparenchymal hemorrhage

Claire J Creutzfeldt et al. Stroke. 2009 Nov.

. 2009 Nov;40(11):e645; author reply e646.

doi: 10.1161/STROKEAHA.109.561191. Epub 2009 Sep 24.

Authors

Claire J Creutzfeldt, Kyra J Becker, W T Longstreth Jr, David L Tirschwell, Jonathan R Weinstein

PMID: 19797180
PMCID: PMC8930190
DOI: 10.1161/STROKEAHA.109.561191

No abstract available

PubMed Disclaimer

Comment on

Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage.
Naidech AM, Jovanovic B, Liebling S, Garg RK, Bassin SL, Bendok BR, Bernstein RA, Alberts MJ, Batjer HH. Naidech AM, et al. Stroke. 2009 Jul;40(7):2398-401. doi: 10.1161/STROKEAHA.109.550939. Epub 2009 May 14. Stroke. 2009. PMID: 19443791

Similar articles

Platelet activity and outcome after intracerebral hemorrhage.
Naidech AM, Bernstein RA, Levasseur K, Bassin SL, Bendok BR, Batjer HH, Bleck TP, Alberts MJ. Naidech AM, et al. Ann Neurol. 2009 Mar;65(3):352-6. doi: 10.1002/ana.21618. Ann Neurol. 2009. PMID: 19334079
Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage.
Naidech AM, Bassin SL, Bernstein RA, Batjer HH, Alberts MJ, Lindholm PF, Bleck TP. Naidech AM, et al. Neurocrit Care. 2009 Dec;11(3):307-10. doi: 10.1007/s12028-009-9219-7. Neurocrit Care. 2009. PMID: 19381881
Platelet hyperfunction exists in both acute non-haemorrhagic and haemorrhagic stroke.
Liu L, Lin Z, Shen Z, Zhang G, Li S, Cao P. Liu L, et al. Thromb Res. 1994 Aug 15;75(4):485-90. doi: 10.1016/0049-3848(94)90264-x. Thromb Res. 1994. PMID: 7997987 Clinical Trial. No abstract available.
[Significance of platelet function tests].
Wolf Z, Mani H, Lindhoff-Last E. Wolf Z, et al. Internist (Berl). 2010 Sep;51(9):1095-6, 1098-100, 1102-8. doi: 10.1007/s00108-009-2569-6. Internist (Berl). 2010. PMID: 20700570 Review. German.
Hematoma Expansion Following Intracerebral Hemorrhage: Mechanisms Targeting the Coagulation Cascade and Platelet Activation.
Burchell SR, Tang J, Zhang JH. Burchell SR, et al. Curr Drug Targets. 2017;18(12):1329-1344. doi: 10.2174/1389450118666170329152305. Curr Drug Targets. 2017. PMID: 28378693 Free PMC article. Review.

See all similar articles

Cited by

Elevated platelet count is associated with decreased mortality from hemorrhagic stroke in hospital: a multi-center retrospective cohort study.
Huang Z, Liu C, Wu Z, Xiao X, Chen Z, Huang Q, Liu D, Deng Z. Huang Z, et al. Sci Rep. 2024 Feb 15;14(1):3797. doi: 10.1038/s41598-024-53956-7. Sci Rep. 2024. PMID: 38360953 Free PMC article.
Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy.
Davis PK, Musunuru H, Walsh M, Cassady R, Yount R, Losiniecki A, Moore EE, Wohlauer MV, Howard J, Ploplis VA, Castellino FJ, Thomas SG. Davis PK, et al. Neurocrit Care. 2013 Apr;18(2):201-8. doi: 10.1007/s12028-012-9745-6. Neurocrit Care. 2013. PMID: 22847397

References

1. Sansing LH, Messe SR, Cucchiara BL, Cohen SN, Lyden PD, Kasner SE. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology. 2009;72:1397–1402. - PMC - PubMed
1. Broderick JP. Evidence against rapid reversal of antiplatelet medications in acute intracerebral hemorrhage. Neurology. 2009;72:1376–1377. - PubMed
1. Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen ER, Hillbom M. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke. 2006;37:129–133. - PubMed
1. Toyoda K, Okada Y, Minematsu K, Kamouchi M, Fujimoto S, Ibayashi S, Inoue T. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology. 2005;65:1000–1004. - PubMed
1. Lacut K, Le Gal G, Seizeur R, Prat G, Mottier D, Oger E. Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality. Fundam Clin Pharmacol. 2007;21:327–333. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information